It was shown that visfatin could upregulate the TYMS expression through p38 signaling and Sp-1 transcription factor and hence decrease the cytotoxicity of capecitabine in human DLD-1 CRC cells. The gene discussed is TYMS; the disease is colorectal carcinoma.